112 related articles for article (PubMed ID: 20042400)
1. Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals.
Chin HJ; Fu YY; Ahn JM; Na KY; Kim YS; Kim S; Chae DW
Nephrol Dial Transplant; 2010 May; 25(5):1450-7. PubMed ID: 20042400
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
Yamabe N; Noh JS; Park CH; Kang KS; Shibahara N; Tanaka T; Yokozawa T
Eur J Pharmacol; 2010 Dec; 648(1-3):179-87. PubMed ID: 20826139
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Lin Y; Sun Z
J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
[TBL] [Abstract][Full Text] [Related]
4. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c.
Wen X; Zeng Y; Liu L; Zhang H; Xu W; Li N; Jia X
J Ethnopharmacol; 2012 Jun; 142(1):144-50. PubMed ID: 22564814
[TBL] [Abstract][Full Text] [Related]
5. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Harima M; Suzuki K; Kawachi H; Watanabe K
J Nutr Biochem; 2013 May; 24(5):796-802. PubMed ID: 22898567
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Hagiwara S; Makita Y; Gu L; Tanimoto M; Zhang M; Nakamura S; Kaneko S; Itoh T; Gohda T; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Mar; 21(3):605-15. PubMed ID: 16282336
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
[TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
[TBL] [Abstract][Full Text] [Related]
9. Effects of proanthocyanidin preparations on hyperlipidemia and other biomarkers in mouse model of type 2 diabetes.
Lee YA; Cho EJ; Yokozawa T
J Agric Food Chem; 2008 Sep; 56(17):7781-9. PubMed ID: 18690694
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
11. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.
Jiang T; Liebman SE; Lucia MS; Phillips CL; Levi M
J Am Soc Nephrol; 2005 Aug; 16(8):2385-94. PubMed ID: 15944339
[TBL] [Abstract][Full Text] [Related]
12. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress.
Zhang M; Hagiwara S; Matsumoto M; Gu L; Tanimoto M; Nakamura S; Kaneko S; Gohda T; Qian J; Horikoshi S; Tomino Y
Metabolism; 2006 Dec; 55(12):1590-8. PubMed ID: 17142129
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
[TBL] [Abstract][Full Text] [Related]
15. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
16. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy.
Gao Q; Qin WS; Jia ZH; Zheng JM; Zeng CH; Li LS; Liu ZH
Planta Med; 2010 Jan; 76(1):27-33. PubMed ID: 19639539
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.
Lee S; Kim W; Moon SO; Sung MJ; Kim DH; Kang KP; Jang KY; Lee SY; Park BH; Koh GY; Park SK
Nephrol Dial Transplant; 2007 Feb; 22(2):396-408. PubMed ID: 17085463
[TBL] [Abstract][Full Text] [Related]
18. Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes.
Okamoto T; Park CH; Noh JS; Toriizuka K; Sei Y; Park JC; Yokozawa T
J Pharm Pharmacol; 2011 Jul; 63(7):952-9. PubMed ID: 21635261
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
Russo LM; del Re E; Brown D; Lin HY
Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H
Hepatology; 2003 Dec; 38(6):1529-39. PubMed ID: 14647064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
